Sign in

CIK 0001041024

  • Non-accelerated filer
  • Smaller reporting company

ROCKWELL MEDICAL, INC.

Sign in to watch
Ticker
RMTI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
383317208
Phone
+1 800-449-3353
Business address
30142 WIXOM ROAD, WIXOM, MI, 48393
Former names
ROCKWELL MEDICAL TECHNOLOGIES INC
  1. 4 Shares withheld for taxes Chief Scientific Officer gave up 15,048 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chairman, President and CEO gave up 73,200 shares (to pay taxes)
  3. 4 Shares withheld for taxes VP of Drug Development gave up 34,650 shares (to pay taxes)
  4. 4 Shares withheld for taxes Vice President, CFO gave up 27,440 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Scientific Officer gave up 31,500 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chairman, President and CEO gave up 46,200 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chairman, President and CEO gave up 260,000 shares (to pay taxes)
  8. 4 Exercise or conversion Director acquired 12,500 shares (option exercise)
  9. 4 Shares withheld for taxes Vice President, CFO gave up 57,500 shares (to pay taxes)
  10. 4 Grant or award VP of Drug Development acquired 75,000 shares (grant or award)
  11. 4 Insider Changes in Ownership
  12. 4 Derivatives Options or other derivatives
  13. 4 Exercise or conversion Chief Scientific Officer acquired 13,000 shares (option exercise)
  14. 4 Grant or award Chairman, President and CEO acquired 200,000 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4/A Derivatives Options or other derivatives
  18. 4/A Derivatives Options or other derivatives
  19. 4/A Open-market sale Director sold 12,500 shares at an average $14.15 ($176,875)
  20. 4/A Open-market sale Director sold 12,500 shares at an average $10.02 ($125,208)

Page 13 of 24 · 470 filings